Taiwan is banking hard on biopharma, and investments that were made in previous decades are now close to bearing fruit. Flush with cash and success, some of Taiwan’s most renowned biopharma firms are on the cusp of bringing to market first-in-class, breakthrough drugs targeting some of humanity’s worst scourges, such as AIDS, cancer, and hepatitis….